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Figure 1 HTG inhibits pancreatic repair after caerulein-induced AP. (A) Representative histological changes in the pancreas of the P407-AP group (the HTG mice) and the phosphate buffer saline (PBS)-AP group (the NTG mice). HTG was induced using 0.5 g/kg P407 in the P407-AP group. The PBS-AP group was administered PBS instead of P407 in the same amount and duration. Similar to their observation, we found another interesting phenomenon that hypertriglyceridaemia (HTG), a prevalent metabolic disorder, delayed pancreatic regeneration after AP in mice and patients. Moreover, the delayed regeneration process could be ameliorated by lipid-lowering therapy.
Two models of HTG (drug induced: poloxamer 407 (P407) and gene modified:
glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) deficiency) were employed to explore the effect of HTG on AP repair. AP induced by caerulein infusion in both normal triglyceride (NTG) mice and HTG mice caused pancreatic acinar cell necrosis. The injured pancreas was reconstructed in 3 days and recovered its normal architecture in 7 days in the NTG mice ( figure 1A-C) . However, we observed reduced morphological recovery in the HTG mice, especially in the severe HTG mice that presented with prolonged necrosis until 7 days (figure 1A-C, online supplementary figures 1-3). Furthermore, the key cellular responses involved in AP repair, including the fibroinflammatory response and acinar cell proliferation, 2 were significantly delayed in the HTG mice (online supplementary figures 4-6). The above results suggested the possibility that the repair process associated with AP may be impeded by HTG.
Many clinical studies have confirmed that HTG exacerbates the severity and prognosis of AP, 3 but the effect of HTG on pancreatic regeneration in patients is still unknown. Here, we conducted a 1-year follow-up study (online supplementary figure 7, supplementary table 1) to investigate the influence of serum triglyceride (TG) levels on pancreatic recovery in patients with severe AP. Obtaining pancreas samples from patients with AP is difficult. Given that the exocrine function of the pancreas is injured after AP resulting in gradual recovery, 4 faecal elastase-1 (FE-1), a hallmark of pancreatic exocrine function, was measured to indirectly evaluate pancreas regeneration. 5 We found that FE-1 levels decreased with an increase in serum TG levels (P trend <0.001; figure 1D ).
We further investigated whether the observed results are reversible by treating HTG with TG-lowering agents after the onset of AP. Fenofibrate, the most common agent used clinically for decades, was repeatedly administered 6 hours after the initial injection of caerulein (figure 2A). Compared with 100 mg/kg/day and 100 mg/kg/twice daily of fenofibrate, 100 mg/kg/three times a day fenofibrate significantly lowered serum TG levels in the HTG-AP mice in 3 days (figure 2B, online supplementary figure 8). Histopathological examination showed no difference in pancreatic morphology between the HTG-AP and fenofibrate-treated groups at 1 day and 3 days, indicating that fenofibrate had no effect on the severity of early-stage AP ( figure 2C,D) . Progressively, compared with the control group, the 100 mg/kg/three times a day fenofibrate-treated HTG group had reduced necrosis and enhanced expansion of acinar cells at 5 days, while the other two dosages had no comparable effect ( figure 2C,D, online supplementary figure 8A,C). In addition, this improvement was not observed in the NTG mice (online supplementary figures 9-10).
In conclusion, we demonstrate that HTG is a risk factor for a delay in AP regeneration, which can be reversed by intensive fenofibrate administration after the onset of AP. Whether TG-lowering therapy is necessary after AP is controversial. 6 Our present results may provide a new perspective for clinical practice. 
